Literature DB >> 16382159

Inhibitor of apoptosis protein cIAP2 is essential for lipopolysaccharide-induced macrophage survival.

Damiano Conte1, Martin Holcik, Charles A Lefebvre, Eric Lacasse, David J Picketts, Kathryn E Wright, Robert G Korneluk.   

Abstract

The cellular inhibitor of apoptosis 2 (cIAP2/HIAP1) is a potent inhibitor of apoptotic death. In contrast to the other members of the IAP family, cIAP2 is transcriptionally inducible by nuclear factor-kappaB in response to multiple triggers. We demonstrate here that cIAP2-/- mice exhibit profound resistance to lipopolysaccharide (LPS)-induced sepsis, specifically because of an attenuated inflammatory response. We show that LPS potently upregulates cIAP2 in macrophages and that cIAP2-/- macrophages are highly susceptible to apoptosis in a LPS-induced proinflammatory environment. Hence, cIAP2 is critical in the maintenance of a normal innate immune inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16382159      PMCID: PMC1346893          DOI: 10.1128/MCB.26.2.699-708.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  27 in total

1.  Unresponsiveness of MyD88-deficient mice to endotoxin.

Authors:  T Kawai; O Adachi; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.

Authors:  X M Sun; W Hsueh
Journal:  J Immunol       Date:  1991-07-15       Impact factor: 5.422

Review 3.  The pathogenesis of septic shock.

Authors:  S Sriskandan; J Cohen
Journal:  J Infect       Date:  1995-05       Impact factor: 6.072

4.  Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP.

Authors:  M G Sanna; C S Duckett; B W Richter; C B Thompson; R J Ulevitch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.

Authors:  A Haziot; S Chen; E Ferrero; M G Low; R Silber; S M Goyert
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

6.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

7.  Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.

Authors:  P Mountford; B Zevnik; A Düwel; J Nichols; M Li; C Dani; M Robertson; I Chambers; A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Non-injection methods for the production of embryonic stem cell-embryo chimaeras.

Authors:  S A Wood; N D Allen; J Rossant; A Auerbach; A Nagy
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

Authors:  C Y Wang; M W Mayo; R G Korneluk; D V Goeddel; A S Baldwin
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

10.  Genomic characterization of the mouse inhibitor of apoptosis protein 1 and 2 genes.

Authors:  P Liston; C Lefebvre; W G Fong; J Y Xuan; R G Korneluk
Journal:  Genomics       Date:  1997-12-15       Impact factor: 5.736

View more
  82 in total

Review 1.  Tumor necrosis factor-α signaling in macrophages.

Authors:  Narayanan Parameswaran; Sonika Patial
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

Review 2.  Death receptor signal transducers: nodes of coordination in immune signaling networks.

Authors:  Nicholas S Wilson; Vishva Dixit; Avi Ashkenazi
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

Review 3.  IAPs: what's in a name?

Authors:  Srinivasa M Srinivasula; Jonathan D Ashwell
Journal:  Mol Cell       Date:  2008-04-25       Impact factor: 17.970

4.  Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis.

Authors:  Luc Friboulet; Catherine Pioche-Durieu; Sandrine Rodriguez; Alexander Valent; Sylvie Souquère; Hugues Ripoche; Abdelmajid Khabir; Sai Wah Tsao; Jacques Bosq; Kwok Wai Lo; Pierre Busson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

Review 5.  Inhibitor of apoptosis proteins in eukaryotic evolution and development: a model of thematic conservation.

Authors:  Mary X D O'Riordan; Laura D Bauler; Fiona L Scott; Colin S Duckett
Journal:  Dev Cell       Date:  2008-10       Impact factor: 12.270

6.  Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages.

Authors:  Ardeshir Ariana; Norah A Alturki; Stephanie Hajjar; Deborah J Stumpo; Christopher Tiedje; Emad S Alnemri; Matthias Gaestel; Perry J Blackshear; Subash Sad
Journal:  J Biol Chem       Date:  2020-02-24       Impact factor: 5.157

7.  miR-155 targets Caspase-3 mRNA in activated macrophages.

Authors:  Rebecca De Santis; Anke Liepelt; Jana C Mossanen; Anne Dueck; Nadine Simons; Antje Mohs; Christian Trautwein; Gunter Meister; Gernot Marx; Antje Ostareck-Lederer; Dirk H Ostareck
Journal:  RNA Biol       Date:  2016       Impact factor: 4.652

8.  IAP inhibitors enhance co-stimulation to promote tumor immunity.

Authors:  Michael Dougan; Stephanie Dougan; Joanna Slisz; Brant Firestone; Matthew Vanneman; Dobrin Draganov; Girija Goyal; Weibo Li; Donna Neuberg; Richard Blumberg; Nir Hacohen; Dale Porter; Leigh Zawel; Glenn Dranoff
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

9.  cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.

Authors:  Hridayesh Prakash; Daniel Becker; Linda Böhme; Lori Albert; Martin Witzenrath; Simone Rosseau; Thomas F Meyer; Thomas Rudel
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

10.  Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.

Authors:  Ana M Jiménez-Lara; Ana Aranda; Hinrich Gronemeyer
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.